Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Lactate in blood, psychotropic agent effects
Lamotrigine clozapine augmentation life-threatening cutaneous reactions target range borderline personality disorder in overdose restarting after period of non-compliance
Laxative misuse/abuse Eating disorders Biochemical and haematological effects of psychotropics
Laxatives Clozapine: common adverse effects Initiation of clozapine in the community Acting on clozapine plasma concentration results Clozapine-induced gastrointestinal hypomotility Safer prescribing for physical conditions in dementia
Learning difficulties capacity and consent general considerations prescribing practice epilepsy comorbidity Learning disabilities
Lemborexant in overdose use in patients with hepatic impairment managing sleep disturbance in dementia
Leukopenia, psychotropic agent effects
Levomepromazine Quick reference for licensed maximum doses Relative adverse effects - a rough guide
Lewy body dementia Dementia Parkinson's disease
Libido
Linaclotide, for constipation treatment
Linear reductions of dose cause increasingly large reductions in effect on GABA-A receptor occupancy.
Lipoproteins in blood, psychotropic agent effects
Lisdexamfetamine attention deficit hyperactivity disorder in adults bulimia nervosa/binge eating disorder borderline personality disorder
Lithium: prescribing and monitoring
Lithium use with
liver function tests (LFTs) interpretation monitoring to access drug effects
Lack of engagement with psychological therapies
Legal issues
Less commonly used treatments, well supported by published evidence (no preference implied by order)
Levetiracetam, for tardive dyskinesia
Licensed maximum doses of antipsychotics, according to US Food and Drug Administration labelling, where available
Linear dose reductions of olanzapine cause increasingly large reductions in D2 dopaminergic receptor blockade.
Linear reductions of dose cause increasingly large reductions in effect on receptor targets, probably associated with more withdrawal effects.
Liraglutide, for antipsychotic-induced weight gain
Lithium: clinically relevant drug interactions
Lithium plasma levels
Lithium
Lofexidine, clozapine-induced hypersalivation
long-acting injectable (LAI)